Get Updates
Get notified of breaking news, exclusive insights, and must-see stories!

Taro Pharma terminates merger agreement with Sun Pharma

New Delhi, May 28 (UNI) Leading drug maker Sun Pharmaceutical Industries Ltd today said its merger agreement with the US-based generic drug maker Taro Pharma has terminated.

In May 2007, Sun Pharmaceutical had signed definitive agreements to acquire Taro Pharma, in a 454 million dollar all-cash deal including net debt of 224 million dollars.

The completion of the acquisition had been repeatedly delayed.

UNI SR RKM BD2122

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+